Добірка наукової літератури з теми "Depression prevalence in a multimorbid population"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Depression prevalence in a multimorbid population".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Depression prevalence in a multimorbid population"
1
Mapanga, Witness, Shane A. Norris, Ashleigh Craig, Yoanna Pumpalova, Oluwatosin A. Ayeni, Wenlong Carl Chen, Judith S. Jacobson, et al. "Prevalence of multimorbidity in men of African descent with and without prostate cancer in Soweto, South Africa." PLOS ONE 17, no. 10 (October 18, 2022): e0276050. http://dx.doi.org/10.1371/journal.pone.0276050.
Повний текст джерелаАнотація:
Objective With increases in chronic disease, men with prostate cancer are likely to have at least one other chronic health condition. The burden and complexity of each additional chronic disease may complicate prostate cancer treatment and reduce survival. In this paper, we describe the frequency of multimorbid chronic diseases, HIV and depression among men in Soweto, South Africa (SA) with and without prostate cancer and determine whether the presence of multimorbid diseases is associated with metastatic and high-risk, non-metastatic prostate cancer. Methods A population-based case-control study on prostate cancer was conducted among black men in Soweto. All participants completed a baseline survey on sociodemographics, lifestyle, and comorbid medical conditions. All participants completed a depression screening survey and HIV testing at enrolment. Blood pressure measurements and blood testing for fasting glucose, total cholesterol, and high-density lipoprotein were performed on a subset of randomly selected cases and controls. For men with prostate cancer, clinical T staging was assessed with the digital rectal examination, the diagnosis was confirmed with a biopsy and PSA levels were assessed at presentation. The metastatic staging was assessed by bone scans, and this was confirmed with PSMA PET scans, CT scans and X-rays, standard for our resource-constrained setting. Normal PSA scores were used as an inclusion criterion for controls. Results Of the 2136 men (1095 with prostate cancer and 1041 controls) included in the analysis, 43.0% reported at least one chronic metabolic disease; 24.1% reported two metabolic diseases; 5.3% reported three metabolic diseases; and 0.3% reported four metabolic diseases. Men with prostate cancer were more likely to report a multimorbid chronic metabolic disease compared to controls (p<0.001) and more likely to test positive for HIV (p = 0.05). The majority of men (66.2%) reported at least one metabolic disease, tested negative for HIV and had a negative depression screen. The clinical characteristics of men with prostate cancer, were as follows: 396 (36.2%) had a Gleason score of 8 and above; 552 (51.3%) had a PSA score of >20ng/ml; 233 (21.7%) had confirmed metastatic prostate cancer at diagnosis. Older age was associated with metastatic prostate cancer (OR = 1.043 95% CI:1.02–1.07) and NCCN defined high-risk non-metastatic prostate cancer (OR = 1.03 95% CI:1.01–1.05), whilst being hypertensive was protective (OR = 0.63 95% CI:0.47–0.84 and OR = 0.55 95% CI:0.37–0.83) respectively for metastatic and high-risk, non-metastatic prostate cancer. Conclusion The high prevalence of multimorbid metabolic diseases and HIV among men with prostate cancer represents a public health concern in South Africa. There is a need to effectively address multiple chronic diseases among men with prostate cancer by incorporating coordinated care models.
2
Chang, Angela Y., Francesc Xavier Gómez-Olivé, Collin Payne, Julia K. Rohr, Jennifer Manne-Goehler, Alisha N. Wade, Ryan G. Wagner, Livia Montana, Stephen Tollman, and Joshua A. Salomon. "Chronic multimorbidity among older adults in rural South Africa." BMJ Global Health 4, no. 4 (August 2019): e001386. http://dx.doi.org/10.1136/bmjgh-2018-001386.
Повний текст джерелаАнотація:
IntroductionThe rapid ageing of populations around the world is accompanied by increasing prevalence of multimorbidity. This study is one of the first to present the prevalence of multimorbidity that includes HIV in the complex epidemiological setting of South Africa, thus filling a gap in the multimorbidity literature that is dominated by studies in high-income or low-HIV prevalence settings.MethodsOut of the full sample of 5059 people aged 40+, we analysed cross-sectional data on 10 conditions from 3889 people enrolled in the Health and Ageing in Africa: A longitudinal study of an INDEPTH Community in South Africa (HAALSI) Programme. Two definitions of multimorbidity were applied: the presence of more than one condition and the presence of conditions from more than one of the following categories: cardiometabolic conditions, mental disorders, HIV and anaemia. We conducted descriptive and regression analyses to assess the relationship between prevalence of multimorbidity and sociodemographic factors. We examined the frequencies of the most prevalent combinations of conditions and assessed relationships between multimorbidity and physical and psychological functioning.Results69.4 per cent (95% CI 68.0 to 70.9) of the respondents had at least two conditions and 53.9% (52.4–55.5) of the sample had at least two categories of conditions. The most common condition groups and multimorbid profiles were combinations of cardiometabolic conditions, cardiometabolic conditions and depression, HIV and anaemia and combinations of mental disorders. The commonly observed positive relationships between multimorbidity and age and decreasing wealth were not observed in this population, namelydue to different epidemiological profiles in the subgroups, with higher prevalence of HIV and anaemia in the poorer and younger groups, and higher prevalence of cardiometabolic conditions in the richer and older groups. Both physical functioning and well-being negatively associated with multimorbidity.DiscussionMore coordinated, long-term integrated care management across multiple chronic conditions should be provided in rural South Africa.
3
Coste, Joël, José M. Valderas, and Laure Carcaillon-Bentata. "Estimating and characterizing the burden of multimorbidity in the community: A comprehensive multistep analysis of two large nationwide representative surveys in France." PLOS Medicine 18, no. 4 (April 26, 2021): e1003584. http://dx.doi.org/10.1371/journal.pmed.1003584.
Повний текст джерелаАнотація:
Background Given the increasing burden of chronic conditions, multimorbidity is now a priority for healthcare and public health systems worldwide. Appropriate methodological approaches for assessing the phenomenon have not yet been established, resulting in inconsistent and incomplete descriptions. We aimed to estimate and characterize the burden of multimorbidity in the adult population in France in terms of number and type of conditions, type of underlying mechanisms, and analysis of the joint effects for identifying combinations with the most deleterious interaction effects on health status. Methods and findings We used a multistep approach to analyze cross-sectional and longitudinal data from 2 large nationwide representative surveys: 2010/2014 waves of the Health, Health Care, and Insurance Survey (ESPS 2010–2014) and Disability Healthcare Household Survey 2008 (HSM 2008), that collected similar data on 61 chronic or recurrent conditions. Adults aged ≥25 years in either ESPS 2010 (14,875) or HSM 2008 (23,348) were considered (participation rates were 65% and 62%, respectively). Longitudinal analyses included 7,438 participants of ESPS 2010 with follow-up for mortality (97%) of whom 3,798 were reinterviewed in 2014 (52%). Mortality, activity limitation, self-reported health, difficulties in activities/instrumental activities of daily living, and Medical Outcomes Study Short-Form 12-Item Health Survey were the health status measures. Multiple regression models were used to estimate the impact of chronic or recurrent conditions and multimorbid associations (dyads, triads, and tetrads) on health status. Etiological pathways explaining associations were investigated, and joint effects and interactions between conditions on health status measures were evaluated using both additive and multiplicative scales. Forty-eight chronic or recurrent conditions had an independent impact on mortality, activity limitations, or perceived heath. Multimorbidity prevalence varied between 30% (1-year time frame) and 39% (lifetime frame), and more markedly according to sex (higher in women), age (with greatest increases in middle-aged), and socioeconomic status (higher in less educated and low-income individuals and manual workers). We identified various multimorbid combinations, mostly involving vasculometabolic and musculoskeletal conditions and mental disorders, which could be explained by direct causation, shared or associated risk factors, or less frequently, confounding or chance. Combinations with the highest health impacts included diseases with complications but also associations of conditions affecting systems involved in locomotion and sensorial functions (impact on activity limitations), and associations including mental disorders (impact on perceived health). The interaction effects of the associated conditions varied on a continuum from subadditive and additive (associations involving cardiometabolic conditions, low back pain, osteoporosis, injury sequelae, depression, and anxiety) to multiplicative and supermultiplicative (associations involving obesity, chronic obstructive pulmonary disease, migraine, and certain osteoarticular pathologies). Study limitations included self-reported information on chronic conditions and the insufficient power of some analyses. Conclusions Multimorbidity assessments should move beyond simply counting conditions and take into account the variable impacts on health status, etiological pathways, and joint effects of associated conditions. In particular, the multimorbid combinations with substantial health impacts or shared risk factors deserve closer attention. Our findings also suggest that multimorbidity assessment and management may be beneficial already in midlife and probably earlier in disadvantaged groups.
4
Vinjerui, Kristin Hestmann, Pauline Boeckxstaens, Kirsty A. Douglas, and Erik R. Sund. "Prevalence of multimorbidity with frailty and associations with socioeconomic position in an adult population: findings from the cross-sectional HUNT Study in Norway." BMJ Open 10, no. 6 (June 2020): e035070. http://dx.doi.org/10.1136/bmjopen-2019-035070.
Повний текст джерелаАнотація:
ObjectivesTo explore prevalences and occupational group inequalities of two measures of multimorbidity with frailty.DesignCross-sectional study.SettingThe Nord-Trøndelag Health Study (HUNT), Norway, a total county population health survey, 2006–2008.ParticipantsParticipants older than 25 years, with complete questionnaires, measurements and occupation data were included.Outcomes≥2 of 51 multimorbid conditions with ≥1 of 4 frailty measures (poor health, mental illness, physical impairment or social impairment) and ≥3 of 51 multimorbid conditions with ≥2 of 4 frailty measures.AnalysisLogistic regression models with age and occupational group were specified for each sex separately.ResultsOf 41 193 adults, 38 027 (55% female; 25–100 years old) were included. Of them, 39% had ≥2 multimorbid conditions with ≥1 frailty measure, and 17% had ≥3 multimorbid conditions with ≥2 frailty measures. Prevalence differences in percentage points (pp) with 95% confidence intervals of those in high versus low occupational group with ≥2 multimorbid conditions and ≥1 frailty measure were largest in women age 30 years, 17 (14 to 20) pp and 55 years, 15 (13 to 17) pp and in men age 55 years, 15 (13 to 17) pp and 80 years, 14 (9 to 18) pp. In those with ≥3 multimorbid conditions and ≥2 frailty measures, prevalence differences were largest in women age 30 years, 8 (6 to 10) pp and 55 years, 10 (8 to 11) ppand in men age 55 years, 9 (8 to 11) pp and 80 years, 6 (95% CI 1 to 10) pp.ConclusionMultimorbidity with frailty is common, and social inequalities persist until age 80 years in women and throughout the lifespan in men. To manage complex multimorbidity, strategies for proportionate universalism in medical education, healthcare, public health prevention and promotion seem necessary.
5
Fleming, Steven T., Nancy E. Schoenberg, Yelena N. Tarasenko, and Kevin A. Pearce. "Prevalence of Colorectal Cancer Screening Among a Multimorbid Rural Appalachian Population." Southern Medical Journal 104, no. 12 (December 2011): 811–18. http://dx.doi.org/10.1097/smj.0b013e31823a8879.
Повний текст джерела
6
Voronkov, L. G., A. V. Liashenko, N. A. Tkach, and L. P. Paraschenyuk. "Chronic heart failure as multimorbid state." Ukrainian Journal of Cardiology 26, no. 4 (October 8, 2019): 90–101. http://dx.doi.org/10.31928/1608-635x-2019.4.90101.
Повний текст джерелаАнотація:
Regulatory, structural and functional disturbances of other organs and systems (kidney, hepar, vessels, skeletal muscles, brain etc) play the substantial role in CHF. These disturbances may be the conseguences of pre-existing states (hypertension, diabetes, hypo- or hyperthyreoidism etc) and from, other side, may reflect the progressive inherent changes in chronic heart failure (CHF) per se. In particular, currently relevant comorbidities in this syndrome are insulin resistance, diabetes mellitus, renal dysfunction, cognitive impairment, depression peripheral myopathy. Every of them demonstrate the close pathophysiologic interplay with CHF which results in clinical prognosis impairment and in decrease of life quality. Prevalence of renal dysfunction described in 39 % of patients with CHF in our research. Renal dysfunction connected with older age, high class of NYHA, diabetes mellitus, arterial hypertension, higher level of citrulline and uric acid in patients with CHF. Patients with iron deficiency characterized with high class of NYHA, low functionality and poor quality of life. In patients with iron deficiency noted high level of mortality and many critical clinical events. Prevalence of cognitive impairment described in 85 % of patients with CHF in our research. Cognitive dysfunction associated with older age, high class of NYHA, diabetes mellitus, arterial hypertension, bad life quality, high level of ceruloplasmin in patients with CHF. Taking to account above-mentioned comorbidities in quideline-recommended management of CHF and the use of additional therapeutic approaches targeted to its treatment represent the contemporary strategy of personalized treatment in this syndrome.
7
Papazoglou, Dimitrios David, Oliver Baretella, Martin Feller, Cinzia Del Giovane, Elisavet Moutzouri, Drahomir Aujesky, Matthias Schwenkglenks, et al. "Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients." PLOS ONE 16, no. 11 (November 16, 2021): e0260112. http://dx.doi.org/10.1371/journal.pone.0260112.
Повний текст джерелаАнотація:
Background Older adults with chronic conditions are at high risk of complications from influenza and pneumococcal infections. Evidence about factors associated with influenza and pneumococcal vaccination among older multimorbid persons in Europe is limited. The aim of this study was to investigate the prevalence and determinants of these vaccinations in this population. Methods Multimorbid patients aged ≥70 years with polypharmacy were enrolled in 4 European centers in Switzerland, Belgium, the Netherlands, and Ireland. Data on vaccinations, demographics, health care contacts, and comorbidities were obtained from self-report, general practitioners and medical records. The association of comorbidities or medical contacts with vaccination status was assessed using multivariable adjusted log-binomial regression models. Results Among 1956 participants with available influenza vaccination data (median age 79 years, 45% women), 1314 (67%) received an influenza vaccination within the last year. Of 1400 patients with available pneumococcal vaccination data (median age 79 years, 46% women), prevalence of pneumococcal vaccination was 21% (n = 291). The prevalence of vaccination remained low in high-risk populations with chronic respiratory disease (34%) or diabetes (24%), but increased with an increasing number of outpatient medical contacts. Chronic respiratory disease was independently associated with the receipt of both influenza and pneumococcal vaccinations (prevalence ratio [PR] 1.09, 95% confidence interval [CI] 1.03–1.16; and PR 2.03, 95%CI 1.22–3.40, respectively), as was diabetes (PR 1.06, 95%CI 1.03–1.08; PR 1.24, 95%CI 1.16–1.34, respectively). An independent association was found between number of general practitioner visits and higher prevalence of pneumococcal vaccination (p for linear trend <0.001). Conclusion Uptake of influenza and particularly of pneumococcal vaccination in this population of European multimorbid older inpatients remains insufficient and is determined by comorbidities and number and type of health care contacts, especially outpatient medical visits. Hospitalization may be an opportunity to promote vaccination, particularly targeting patients with few outpatient physician contacts.
8
Gopal, Sindhu, Meena Chacko, PunitaA Sharma, and D. Mitra. "Prevalence of depression among geriatric population." Indian Journal of Psychiatric Nursing 15, no. 2 (2018): 42. http://dx.doi.org/10.4103/2231-1505.262450.
Повний текст джерела
9
Ishtiaq, Muhammad, Muhammad Imtiaz Afridi, Imranullah -, and Said Akbar Khan. "DEPRESSION." Professional Medical Journal 25, no. 08 (August 4, 2018): 1229–34. http://dx.doi.org/10.29309/tpmj/2018.25.08.39.
Повний текст джерелаАнотація:
Prevalence & risk factors of depression among adult population of districtPeshawar. Background: Depression is one of the most common major mental illnesses andaffects 5% to 20% of the adult population and is related to many determinants. Objectives:To estimate the prevalence and risk factors of depression among the adult population. StudyDesign: A cross sectional descriptive study. Setting & Study Duration: The department ofcommunity medicine, Khyber medical college, Peshawar; among the adult population of districtPeshawar; from November 2016 to May 2017. Materials & Methods: A total of 410 adults, bothmale and female, of ages 18 and above years were selected from the District Peshawar; onthe basis of multistage probability sampling technique. A structured questionnaire was usedto collect data regarding the prevalence and risk factors of depression along with importantvariables. Data was analysed by Microsoft Office and SPSS, and results were presented intables. Results: Results showed that the prevalence of depression was 85.85%. Out of thetotal depression, 24.88% had positive medical history; 57.8% had tobacco smoking; 29.02 %had history of abuse or neglect; 60.24% had sleep problems; and 18.29% & 10.49% wereaffected by terrorism and flood respectively. Conclusions: It was concluded that the prevalenceof depression among the adult population of district Peshawar was high and shows strongassociation with predisposing determinants. Moreover, whole population needs to be screento estimate the accurate prevalence and to treat high burden of mental illnesses among thecommunity.
10
Scholten, Mia, Patrik Midlöv, and Anders Halling. "Disparities in prevalence of heart failure according to age, multimorbidity level and socioeconomic status in southern Sweden: a cross-sectional study." BMJ Open 12, no. 3 (March 2022): e051997. http://dx.doi.org/10.1136/bmjopen-2021-051997.
Повний текст джерелаАнотація:
ObjectiveThe aim of this study was to compare the prevalence of heart failure (HF) in relation to age, multimorbidity and socioeconomic status of primary healthcare centres in southern Sweden.DesignA cross-sectional study.SettingThe data were collected concerning diagnoses at each consultation in all primary healthcare centres and secondary healthcare in the southernmost county of Sweden at the end of 2015.ParticipantsThe individuals living in southern Sweden in 2015 aged 20 years and older. The study population of 981 383 inhabitants was divided into different categories including HF, multimorbidity, different levels of multimorbidity and into 10 CNI (Care Need Index) groups depending on the socioeconomic status of their listed primary healthcare centre.OutcomesPrevalence of HF was presented according to age, multimorbidity level and socioeconomic status. Logistic regression was used to further analyse the associations between HF, age, multimorbidity level and socioeconomic status in more complex models.ResultsThe total prevalence of HF in the study population was 2.06%. The prevalence of HF increased with advancing age and the multimorbidity level. 99.07% of the patients with HF fulfilled the criteria for multimorbidity. The total prevalence of HF among the multimorbid patients was only 5.30%. HF had a strong correlation with the socioeconomic status of the primary healthcare centres with the most significant disparity between 40 and 80 years of age: the prevalence of HF in primary healthcare centres with the most deprived CNI percentile was approximately twice as high as in the most affluent CNI percentile.ConclusionThe patients with HF were strongly associated with having multimorbidity. HF patients was a small group of the multimorbid population associated with socioeconomic deprivation that challenges efficient preventive strategies and health policies.
Дисертації з теми "Depression prevalence in a multimorbid population"
1
Zitha, Eddy. "Prevalence of anxiety and depression in a predominantly HIV-infected population with severe cutaneous adverse drug reactions." Master's thesis, University of Cape Town, 2016. http://hdl.handle.net/11427/21378.
Повний текст джерелаАнотація:
Background: There is limited data on anxiety and depression in subjects with severe cutaneous adverse drug reactions (SCADR), in a predominantly HIV - infected population. The aim of the study was to prospectively investigate the prevalence of anxiety and depression and quality of life in patients with SCADR. Methods: In this prospective study, SJS, SJS - TEN, TEN and DRESS patients were assessed for anxiety and depression using validated scoring systems, the Hospital Anxiety and Depression Scale (HAD S), and the Dermatology Life Quality Index (DLQI). This was done at six weeks post discharge and again at six months follow - up. Results: Forty - eight patients with SCADR were enrolled at six weeks and 37/48 (77%) completed the study at six months. The populations were similar demographically at six weeks and six months. At six weeks anxiety or borderline anxiety symptoms/caseness was identified in 25/48 (52%) SCADR patients and depression or borderline depression symptoms/caseness in 24/48 (50%). Of those with symptoms, 18 were assessed as having co - morbid anxiety and depression with only 2 cases of pure anxiety and 4 of pure depression. At six months only 37 patients with SCADR returned for follow - up. Four of them had died in the interim while the other seven relocated. Of the cases of pure anxiety; one resolved and one was lost to follow - up. Of the cases of pure depression; one resolved, one persisted, one converted to comorbid anxiety and depression and one was lost to follow - up. Of those with co - morbid anxiety and depression 10 persisted, 2 converted to pure depression, 3 normalised and 2 were lost to follow - up. One previously normal patient developed anxiety symptoms and one case developed comorbid anxiety and depression. In 9/13 (69%) of the patients with SJS, SJS - TEN and TEN, co - morbid anxiety and depression persisted from week six to 6 months. In contrast in only 1/5 (20%) of the patients with DRESS, co - morbid anxiety and depression persisted from week six to 6 months. The cases of pure anxiety and depression were too small for meaningful comment. The overall SJS, SJS - TEN and TEN had median DLQI 8.4 relative to DRESS (DLQI 7.5) at six weeks. However, TEN (DLQI 14) had a greater impact on the quality of life compared to SJS (DLQI 3) and DRESS (DLQI 7.5). This pattern was maintained at six months. Conclusion: Anxiety and depression in patients with SCADR in a predominantly HIV - infected population is present. In the majority of cases, depression and anxiety coexist in patients with SCADR. These are sustained for at least 6 months post discharge. SCADR has a negative impact on quality of life. Our findings should help to improve the awareness of the impact of severe cutaneous adverse drug reactions on mental health especially as this may impact on future treatment adherence.
2
Fellmeth, Gracia. "Perinatal depression in refugee and labour migrant women on the Thai-Myanmar border : prevalence, risk factors and experiences." Thesis, University of Oxford, 2018. https://ora.ox.ac.uk/objects/uuid:d57fc610-dd6a-4ccd-a1c5-6d5a3a773f5d.
Повний текст джерелаАнотація:
Background: Perinatal depression is a significant contributor to maternal morbidity and mortality worldwide. Left untreated, perinatal depression has severe and far-reaching consequences for women, their families and wider society. Migrant women, including labour migrants and refugees, may be particularly prone to developing perinatal depression as a result of multiple stressors associated with displacement. Despite the vast majority of global migration flows occurring within low- and middle-income countries, evidence from these regions is severely lacking. This research addresses this imbalance by examining perinatal depression in migrant women living on the Thai-Myanmar border: a resource-poor setting of political tension and socio-economic disadvantage. Aims: This research aims to review the existing evidence around perinatal depression among migrant women from low- and middle-income settings; identify an appropriate tool to detect perinatal depression in migrant women on the Thai-Myanmar border; determine the prevalence of, and risk factors for, perinatal depression in this setting; explore women's experiences of perinatal depression; and develop recommendations for policy and practice. Methods: A sequential-exploratory mixed-methods design was used. The research included the following five study components: a systematic literature review; a validation study to identify a culturally-acceptable and appropriate assessment tool; a prospective cohort study of migrant women on the Thai-Myanmar border followed-up from the first trimester of pregnancy to one month post-partum; in-depth interviews with a subgroup of women with severe perinatal depression; and an informal exploration of stakeholder views. Findings: The systematic review found a wide range in prevalence of perinatal depression among migrant women and confirmed the absence of studies conducted in low-and middle-income destination countries. A total of 568 migrant women on the Thai-Myanmar border participated in the prospective cohort study, of whom 18.5% experienced moderate-severe depression and 39.8% experienced depression of any severity during the perinatal period. Almost a third (29%) of women reported suicidal ideation. Interpersonal violence (OR 4.5), experience of trauma (OR 2.4), a self-reported history of depression (OR 2.3) and perceived insufficiency of social support (OR 2.1) were significantly associated with perinatal depression. Lives of women with severe perinatal depression were characterised by difficult partner relationships, alcohol use among partners and interpersonal violence. A lack of mental health services currently limits the effective management of perinatal depression in this setting. Alongside training of health staff, primary, secondary and tertiary prevention efforts are required to effectively address perinatal depression on the Thai-Myanmar border.
3
Stanners, Melinda Nicole. "An exploration of the prevalence, diagnosis and treatment of depression in patients with multiple chronic conditions." Thesis, 2013. http://hdl.handle.net/2440/82543.
Повний текст джерелаАнотація:
Introduction: The likelihood of developing two or more chronic illnesses (‘multimorbidity’) increases with age. Depression is common with chronic physical illness, but may not be detected or treated in multimorbid patients. This thesis is comprised of a series of related studies designed to explore the prevalence, diagnosis and management of depression in patients with multiple chronic conditions using an explanatory mixed methods design. Data and participants were sourced from a multidisciplinary outpatient clinic in metropolitan Adelaide. Study One: Clinic Database Analysis. The study estimated the prevalence of a) depression diagnoses and b) depressive symptoms using the Geriatric Depression Scale (GDS) in an outpatient clinic population, exploring agreement between clinician diagnoses of depression and GDS scores. Doctor-diagnosed depression was recorded for 15% of patients. Based on GDS scores, 50% of patients reported threshold-level depression symptoms, although many had no corresponding depression diagnosis. This suggests that whilst many multimorbid patients experience depressive symptoms, these may not be detected. Study Two: Comparing the GDS, HADS and CIDI. Study Two compared GDS scores with Hospital Anxiety and Depression Scale (HADS) scores and Composite International Diagnostic Interview (CIDI) diagnoses. The GDS identified more depression-positive cases than the HADS and the CIDI, but the CIDI failed to detect severe depressive symptoms in several patients. During the study, concerns arose relating to the use of the CIDI with older multimorbid patients; consequently, the study was terminated early. Study Three: Patient Symptom Priority Scale. The Patient Symptom Priority Scale was developed to explore patient perceptions of symptom burden and functional impact, and piloted in the clinic. Patients described more physical symptoms than emotional symptoms. Age correlated positively with chronic illness and physical symptom counts, and negatively with psychological symptom impact. Geriatric Depression Scale scores correlated with all psychological variables. Study Four: GP experiences of depression diagnosis and management with multimorbid patients.
Semi-structured interviews were conducted with GPs who had referred patients to the clinic, to explore GP perceptions of depression diagnosis and treatment with multimorbid patients and generate a grounded theory model reflecting the role of multimorbidity in their practice. Multimorbidity generated increased time to determine symptom causation and build relationship with the patient. GPs offered medical and social depression interventions.
Study Five: Experiences of depression diagnosis and treatment amongst multimorbid patients.
To explore the patient perspective, further qualitative interviews were undertaken with multimorbid clinic patients who had been diagnosed with depression. Thematic analysis revealed common diagnosis and treatment experiences amongst these multimorbid patients with depression. All patients attributed depression onset to the loss of their normal life, with stigma emerging as an underlying influence in patient decisions about treatment.
Conclusion: This is the first study to compare depression symptoms with depression diagnoses in a multimorbid population, and found that many patients experience threshold-level depression symptoms that are not being addressed. General practitioners are aware of contextual factors, and try to address them, but also make assumptions about their patients that may not be accurate. This may account for the number of patients still suffering. The findings suggest that a thorough symptom profile is necessary for effective detection and treatment of depression in this vulnerable population.Thesis (Ph.D) -- University of Adelaide, School of Medicine, 2013
4
Hatch, Brandon Robert Tortolero Susan Rohrabacher. "Prevalence of depressive symptoms in urban middle and high school Hispanic and African American students." 2007. http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqdiss&rft_dat=xri:pqdiss:1444745.
Повний текст джерела
5
Gouveia, Nélia Sofia Augusto. "The burden of chronic low back pain in the adult Portuguese population : an epidemiological population-based study under the scope of Epireumapt." Doctoral thesis, 2015. http://hdl.handle.net/10362/16714.
Повний текст джерелаАнотація:
RESUMO: Nos países desenvolvidos a lombalgia é a condição músculo-‐esquelética mais prevalente. Quando evolui para um quadro crónico é responsável por um encargo económico bastante considerável, não só em relação aos indivíduos, mas também para a sociedade. A lombalgia crónica é por isso uma das principais causas de perda de produtividade e de perda de independência económica, nomeadamente através do absenteísmo (ausência do trabalho), do presenteísmo (perda de produtividade no trabalho, devido à capacidade diminuída provocada pela lombalgia) e da incapacidade para trabalhar (invalidez permanente, total ou parcial). Até à data, em Portugal, a prevalência e carga social da lombalgia crónica eram desconhecidas. Até agora não existiam estudos populacionais de grande dimensão sobre este tema. O objetivo principal desta tese foi determinar a prevalência de lombalgia crónica, e também avaliar a carga social que esta tem na população adulta Portuguesa. O trabalho de investigação foi desenvolvido no âmbito do Estudo Epidemiológico de Doenças Reumáticas em Portugal (EpiReumaPt). Este foi o primeiro estudo de larga escala e de base populacional, que determinou a prevalência de doenças reumáticas e músculo-‐ esqueléticas na população adulta portuguesa. Foi realizado numa amostra aleatória e representativa, de 10.661 indivíduos do Continente, da Região Autónoma dos Açores e da Região Autónoma da Madeira, entre Setembro de 2011 e Dezembro de 2013. Esta tese foi dividida em duas secções. A primeira secção incluiu o detalhe das questões relativas ao desenvolvimento e gestão do EpiReumaPt, constituindo-‐se como um guia prático sobre como realizar um estudo de base populacional de larga escala, em Portugal. A metodologia detalhada do EpiReumaPt foi também descrita nesta secção e incluiu os objectivos, o desenho do estudo, as características de recrutamento e a preparação de dados para análise. Nesta secção foram ainda descritos os principais resultados do EpiReumaPt. Estes evidenciaram que a lombalgia foi a condição músculo-‐esquelética com maior prevalência na população adulta portuguesa.A segunda secção desta tese estimou a prevalência da lombalgia crónica ativa na população adulta Portuguesa, e avaliou a carga social esta condição. A lombalgia ativa foi definida com base na dor auto-‐relatada no dia da entrevista e que persistia há pelo menos 90 dias (independentemente da causa). A lombalgia foi definida como dor na área definida entre a margem inferior das décimas segundas costelas até às pregas glúteas inferiores, com ou sem dor nos membros inferiores. A carga social foi medida tendo em conta os seguintes parâmetros: qualidade de vida, função, consumo de recursos de saúde, consumo de analgésicos e outros fármacos
usados no alívio da dor, sintomas de ansiedade e sintomas de depressão. Os resultados mostraram que o
consumo de recursos em saúde e a carga social da lombalgia crónica na população adulta Português é significativa. Também a incapacidade causada pela lombalgia crónica,nos indivíduos com idade ativa, é responsável por elevadas taxas de absenteísmo e má qualidade de vida, aos quais acresce o consequente ónus socioeconómico. Esta tese também concluiu que o consumo de analgésicos e outros medicamentos para alívio da dor, na população adulta portuguesa com lombalgia crónica ativa, é relativamente baixa. A maioria destes indivíduos não tomava nenhum medicamento analgésico, independentemente da intensidade da dor. Mesmo os indivíduos que reportaram dor intensa, apenas 4.0% estavam no primeiro degrau da escada analgésica da Organização Mundial de Saúde; 2.3% usavam opióides fracos e 0.03% usavam opióides fortes para controlar a dor (segundo e terceiro degrau da escada analgésica da Organização Mundial da Saúde). O trabalho de investigação também confirmou que a prevalência de sintomas de ansiedade e depressão entre os indivíduos adultos portugueses com lombalgia crónica ativa é elevada. Nestes indivíduos, registou-‐se um consumo mais elevado de analgésicos e outros medicamentos para alívio da dor, quando comparados com os indivíduos com lombalgia crónica activa sem esses sintomas psicológicos. Os grupos terapêuticos mais utilizados foram os ansiolíticos, sedativos e hipnóticos, os antidepressivos e os anti-‐inflamatórios não esteróides. A intensidade média da dor reportada foi também maior entre os indivíduos com lombalgia ativa e sintomas de ansiedade e/ou depressão. Também nestes, foi reportada pior função e pior estado de saúde. Em relação ao consumo de recursos de saúde foram encontradas diferenças significativas entre as duas populações: os indivíduos com lombalgia ativa e sintomas psicológicos concomitantes registaram maior número de consultas de psiquiatria de outras especialidades médicas, assim como precisaram de mais apoio domiciliário nos 12 meses prévios à entrevista do EpiReumaPt. Foram também identificados os fatores associados a sintomas isolados de ansiedade, a sintomas isolados de depressão e a sintomas de ansiedade e depressão. Resumindo,esta tese permitiu concluir que a lombalgia crónica é um problema de saúde comum na população adulta portuguesa, contribuindo para um elevado grau de incapacidade e que consequentemente afeta o desempenho laboral e o bem-‐estar dos indivíduos. A lombalgia crónica é também responsável por um consumo considerável de recursos de saúde. Acresce ainda que os sintomas
de ansiedade e depressão são comuns, entre os indivíduos com lombalgia crónica, contribuindo com uma carga social adicional.---------------------------------- ABSTRACT:Low Back Pain(LBP) is the most prevalent of musculoskeletal condition in developed countries.When it becomes chronic, LBP causesan enormous economic burden on individuals and society -‐ it is one of the leading causes of loss of productivity and economic independence through absenteeism (time off work), presenteeism (lost productivity because of
diminished capacity while at work) and work disability (permanent, partial or complete disablement for work
purposes). In Portugal the prevalence and burden of LBP and chronic LBP (CLBP) were poorly defined. Until now no large population-‐based studies have focused on this. The main aim of this thesis was to determine the prevalence of LBP and CLBP, and also to assess the burden of CLBP in the adult rtuguese population. The research work was developed under the scope of EpiReumaPt (the Portuguese Epidemiologic Study of Rheumatic Diseases). EpiReumaPt was the first national large population-‐based and prevalence study of rheumatic and musculoskeletal diseases (RMD). It was performed among a
randomized and representative sample of 10,661 adult Portuguese subjects recruited in Mainland, Azores and Madeira Islands, from September 2011 to December 2013. The first section of this thesis included detailed issues regarding the development and management of EpiReumaPt, and provided a practical guide on how to set-‐up a large population-‐based study in Portugal. The detailed methodology of EpiReumaPt, including its objectives,study design,recruitment features,and data preparation for analyses were also described. The main results from EpiReumaPt study were provided in this section and showed that LBP was the musculoskeletal condition with highest prevalence among Portuguese population. The second section of this thesis estimated the prevalence of active CLBP among adult Portuguese population, and assessed the social burden of this condition. Active CLBP was defined based on self-‐reported pain on the day of the interview, and for most of the time for at least 90 days (independently from cause). LBP was defined as pain in the back area from the lower margin of the twelfth ribs to he lower gluteal folds, with or without pain referred to the lower limbs. Social burden was measured taking into account the following outcomes: quality of life, function, healthcare resources consumption, analgesic and other pain relief drugs intake, anxiety and depression symptoms. Results showed that the healthcare consumption and social burden of CLBP among adult Portuguese population were enormous, and the disability caused by CLBP
among subjects in a working age provides high rates of absenteeism (work loss) and poor quality of life, with a consequent socioeconomic burden. This thesis also concluded that analgesic and other pain relief drugs untake among adult Portuguese population with active CLBP was very low. Most of the subjects with active CLBP did not take any analgesic drug regardless pain severity. Even when subjects self-‐reported severe pain, only 24.0% were in the 1st step of the analgesic ladder,2.3% used weak analgesic opioids and 0.03% used strong opioids (2nd and 3rd step of WHO analgesic ladder, respectively) to control pain . The research work also confirmed that the prevalence of anxiety and depression symptoms among adult Portuguese subjects with active CLBP was high. Regarding pharmacological therapy, the intake of analgesic and other pain relief drugs was higher among subjects with anxiety and/or depression symptoms,
when compared with subjects without these psychological symptoms. Anxiolytics, sedatives and hypnotics, antidepressants and NSAIDs intake had higher usage rates among these subjects. The pain severity mean
was also higher among this subjects and function and health status was worse. Regarding healthcare
resources consumption,significant differences between the two populations were found. Subjects with ctive
CLBP and concomitant psychological symptoms had a higher number of psychiatrist and other physician
visits. They also needed more home care in the previous 12 months. Factors associated with isolated symptoms of anxiety, depression,and concomitant anxiety and depression symptoms were also identified.
Summarizing, we concluded that CLBP is a common health problem among adult Portuguese population contributing to disability and affecting labor performance, and the well being of subjects. it is also
responsible for considerable healthcare resource consumption. Anxiety and depression symptoms are
common among subjects with CLBP and provided an additional burden among them.
Книги з теми "Depression prevalence in a multimorbid population"
1
Casey, Patricia. How common is adjustment disorder? (DRAFT). Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198786214.003.0002.
Повний текст джерелаАнотація:
Most of the large-scale epidemiological studies have neglected AD, although there are some recent smaller studies that have included it. The diagnostic tools in common use, such as SCAN or SCID, either omit AD or only allow the diagnosis to be made when all other disorders have been considered. Studies using these have found a prevalence of less than 2% in the general population or among those attending primary care. Two instruments specific for AD have been published in recent years. The ADNM is a screening instrument based on the proposed ICD-11 criteria, while the DIAD is a diagnostic tool. With these instruments, the prevalence has been shown to be much higher than earlier studies indicated, and in some settings such as liaison psychiatry its frequency eclipsed that of major depression. It is likely that the enhanced status of AD will result in more epidemiological studies that incorporate AD as well as other common disorders.
2
Douaihy, Antoine, Melanie Grubisha, Maureen Lyon, and Mary Ann Cohen. Trauma and Posttraumatic Stress Disorder—The Special Role in HIV Transmission. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0017.
Повний текст джерелаАнотація:
The prevalence of posttraumatic stress disorder (PTSD) in persons with HIV is higher than in the general population. Adults with HIV are likely to have experienced traumatic events that place them at risk for developing PTSD. Among women with HIV, PTSD may be more common than depression, suicidality, and substance use. The high prevalence of PTSD is related to increased exposure to traumatic experiences such as physical violence and sexual assault, including intimate partner violence and childhood sexual abuse. The co-occurrence of PTSD and HIV creates complex challenges for both the management of HIV and treatment of PTSD. Individuals with PTSD and HIV experience more rapid illness progression and poorer health-related quality of life, with health-compromising behaviors such as substance use, high-risk sexual behavior, poor utilization of services, and low adherence to antiretroviral therapy. This chapter addresses the complexities of HIV, trauma, and PTSD and recommends trauma-informed care in the treatment of people living with HIV and AIDS.
3
Cournos, Francine, Karen McKinnon, and Milton Wainberg. Epidemiology of Psychiatric Disorders Associated with HIV and AIDS. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0003.
Повний текст джерелаАнотація:
This chapter presents the prevalence of common and severe mental illnesses among people with HIV infection, as well as the prevalence of HIV infection among people with severe mental illness. It begins with a look at population-based studies, which are limited in number, then discusses specific disorders studied in smaller studies with selected populations. While the chapter is largely focused on epidemiology in the United States, selected studies from other regions are cited. Taken together, studies show that people with HIV infection have high rates of HIV-associated neurocognitive disorders, although these disorders tend to be milder than they were before effective antiretroviral therapy. The rates of current alcohol- and drug-related disorders mirror those for the general population, but lifetime rates among people with HIV infection are higher, as are rates of depression, anxiety disorders, posttraumatic stress disorder, bipolar disorder, psychosis and personality disorder. Rates of HIV infection among people with severe mental illness in the U.S. are clearly elevated in comparison to those for the general population. Despite scientific advances, the absence of a strong focus on mental disorders remains a glaring omission in progress on HIV prevention, care, and treatment.
4
Baune, Bernhard T., and Catherine Harmer, eds. Cognitive Dimensions of Major Depressive Disorder. Oxford University Press, 2019. http://dx.doi.org/10.1093/med/9780198810940.001.0001.
Повний текст джерелаАнотація:
The lifetime prevalence of 15% for major depressive disorder (MDD) within the general population is among the highest among all mental disorders. MDD is also one of the leading causes of disability and has been estimated to affect 300 million people worldwide. Clinical, functional, and biological correlates of MDD are frequently investigated almost exclusively based on research that defines depression as a categorical disorder assessed by established diagnostic instruments. Given the phenotypic and biological heterogeneity of depression, a refocus of the clinical phenotype of depression is required and widely recommended. Cognitive dimensions of depression have long been implicated in the nature of depression as a disorder that is characterized by typically impaired cognitive and emotional processes. The systems of cognitive function, emotion processing, and social cognitive processing are regarded as comprehensively describing large parts of the clinical symptoms as well as the pathophysiology of the brain-based disorder of depression. The focus on the above cognitive and emotional dimensions of depression offers promising extended and novel diagnostic and treatment approaches ranging from pharmacological to psychological interventions targeting those dimensions of depression. This book aims to provide an improved understanding of the characteristics of the dimensional approach of depression, focusing on the cognitive, emotional, and social cognitive processes.
5
Modir, Shahla J., and John Tsuang. Psychiatric Assessment and Co-Occurring Disorders. Edited by Shahla J. Modir and George E. Muñoz. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190275334.003.0012.
Повний текст джерелаАнотація:
This chapter on co-occurring disorders examines issues pertaining to substance-use disorder and psychiatric illnesses. It takes a very close look at prevalence, diagnoses, and medication treatment strategies for both psychiatric disorders, as well as for substance-use disorders. The chapter puts special emphasis on psychiatric disorders such as depression, bipolar disorder, anxiety, psychosis, and attention deficit hyperactivity disorder. Complementary treatment tools such as use of various vitamins, fish oil, and other natural chemical agents are reviewed here as well. Finally, alternative therapies such as social rhythm therapy, exercise, neurofeedback, and meditation—which can all integrate into treatment of this population—are presented and examined.
6
Hanney, Maria Luisa. Older people with learning disabilities. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199644957.003.0050.
Повний текст джерелаАнотація:
Elderly people with Learning Disabilities are a heterogeneous clinically complex population with unique medical and social challenges. Little is known of the epidemiology of mental ill health in this group. Emerging evidence indicates that they suffer higher rates of mental illness than the general population and than their younger peer group. Point prevalence of mental ill health in elderly people with Learning Disabilities has been reported about 69% compared with 48% in the younger peer group. This higher rate of psychiatric diagnosis in the older group is mainly due to a higher rate of dementia of about 21 %. People with Down syndrome appear to have lower rates of mental ill health apart from depression and early onset dementia of Alzheimer’s type. People with Learning Disability due to other causes are also at higher risk of developing dementia at an earlier age than the general population
7
Hatfield, Catherine, and Tom Dening. Severe and enduring mental illness. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199644957.003.0048.
Повний текст джерелаАнотація:
Severe and enduring mental illness refers mainly to the long term experience of schizophrenia and psychosis but also to other chronic functional disorders. The prevalence of psychoses in older people is hard to measure but estimates are around 0.5% of the population. Historically many people with long term illness resided in psychiatric hospitals but now most are in the community, receiving variable amounts of support from mental health, primary care, and social services. The physical health of this population is often poor and they receive less treatment and support than other older people with comparable physical health needs. Problems with psychiatric comorbidity (e.g. depression and substance misuse), cognitive impairment and social exclusion are also common. Treatment includes the judicious use of medication, non pharmacological approaches, and social support – especially appropriate accommodation. Positive outcomes can be achieved by a recovery approach that attends to all aspects of the person’s health.
8
Mueser, Kim T., Douglas L. Noordsy, and Robert E. Drake. Serious Mental Illness. Edited by Kenneth J. Sher. Oxford University Press, 2014. http://dx.doi.org/10.1093/oxfordhb/9780199381708.013.009.
Повний текст джерелаАнотація:
The high comorbidity between substance use disorders and serious mental illnesses is a significant challenge to traditional treatment systems that have historically treated psychiatric and substance use disorders with different providers and agencies. Defining characteristics of serious mental illness include difficulty with work, performing in school or parenting, social difficulties, and problems caring for oneself. Common serious psychiatric disorders include schizophrenia, schizoaffective disorder, bipolar disorder, and severe major depression, posttraumatic stress disorder, and borderline personality disorder. The epidemiology of substance use disorders in serious mental illness is reviewed, including prevalence, correlates, and onset and course of the disorder. The clinical consequences of substance use disorders in this population are devastating for every possible aspect of the illness. Common factors may increase vulnerability to both substance abuse and psychiatric disorders. The principles of treating co-occurring disorders are based on modern integrated methods, as well as research on the effectiveness of integrated treatment.
9
Alosco, Michael L., and Robert A. Stern, eds. The Oxford Handbook of Adult Cognitive Disorders. Oxford University Press, 2019. http://dx.doi.org/10.1093/oxfordhb/9780190664121.001.0001.
Повний текст джерелаАнотація:
The prevalence of cognitive impairment caused by neurodegenerative diseases and other neurologic disorders associated with aging is expected to rise dramatically between now and year 2050, when the population of Americans aged 65 or older will nearly double. Cognitive impairment also commonly occurs in other neurologic conditions, as well as in non-neurologic medical disorders (and their treatments), idiopathic psychiatric illnesses, and adult neurodevelopmental disorders. Cognitive impairment can thus infiltrate all aspects of healthcare, making it necessary for clinicians and clinical researchers to have an integrated knowledge of the spectrum of adult cognitive disorders. The Oxford Handbook of Adult Cognitive Disorders is meant to serve as an up-to-date, scholarly, and comprehensive volume covering most diseases, conditions, and injuries resulting in impairments in cognitive function in adults. Topics covered include normal cognitive and brain aging, the impact of medical disorders (e.g., cardiovascular, liver, pulmonary) and psychiatric illnesses (e.g., depression and bipolar disorder) on cognitive function, adult neurodevelopmental disorders (e.g., Down Syndrome, Attention Deficit/Hyperactivity Disorder), as well as the various neurological conditions (e.g., Alzheimer’s disease, chronic traumatic encephalopathy, concussion). A section of the Handbook is also dedicated to unique perspectives and special considerations for the clinicians and clinical researchers, covering topics such as cognitive reserve, genetics, diversity, and neuroethics. The target audience of this Handbook includes: (1) clinicians, particularly psychologists, neuropsychologists, neurologists (including behavioral and cognitive neurologists), geriatricians, and psychiatrists (including neuropsychiatrists), who provide clinical care and management for adults with a diverse range of cognitive disorders; (2) clinical researchers who investigate cognitive outcomes and functioning in adult populations; and (3) graduate level students and post-doctoral trainees studying psychology, clinical neuroscience, and various medical specialties.
Частини книг з теми "Depression prevalence in a multimorbid population"
1
Wolanin, Andrew T. "Depression in Athletes: Incidence, Prevalence, and Comparisons with the Nonathletic Population." In Mental Health in the Athlete, 25–37. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-44754-0_3.
Повний текст джерела
2
Vega, William A., and William M. Sribney. "Latino Population Demographics, Risk Factors, and Depression: A Case Study of the Mexican American Prevalence and Services Survey." In Issues in Children's and Families' Lives, 29–52. Boston, MA: Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-78512-7_2.
Повний текст джерела
3
Mittal, Komal, A. Philo Magdalene, and Drishya Pathak. "A Lifestyle Disorder that Spared Nobody: Mental Health and COVID-19." In Health Dimensions of COVID-19 in India and Beyond, 157–69. Singapore: Springer Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-7385-6_8.
Повний текст джерелаАнотація:
AbstractThe authors discuss the mental health problems that emerged during the COVID-19 pandemic. Mental health manifested as a lifestyle disorder that is being experienced by everybody all around the world. The authors discuss a range of mental health problems that are due to COVID-19. Their prevalence and implications are assessed. In order to provide perspective, research from India and other countries is cited. The causes and consequences of mental health problems associated with COVID-19 are analyzed.In India, mental health problems were on the rise even before the pandemic. The pandemic, however, greatly exacerbated these problems. Stress, anxiety, and depression became a part of everyone’s life. No one was spared. Strong public health measures to contain the pandemic including the prohibition of movement and isolation took their toll. Being away from work, school, and peers, adjusting to new ways of working and learning, and dealing with job loss were all stressful. Fake news and miscommunication further fueled the problem.A large section of the population was forced to re-invent its workplace, often in unfavorable environments, resulting in a deep sense of unease. Research shows that because of uncertainties related to finances, work pressure, and jobs, there was a rise in the number of cases of mental illness. The number of suicides also increased. Research in India and other countries underscores that COVID-19 compounded all these problems. Stringent public health measures imposed by all governments, although necessary for containing the pandemic, had a major impact on the psychological state of people. Fear, anxiety, and anger are some of its psychological consequences. Anxiety producing information in the media accentuated these problems.Pre-occupation with the pandemic resulted in a neglect of the mental well-being of the patients, healthcare professionals, and frontline workers. This caused psychological distress that varied from panic attacks and collective hysteria to pervasive feelings of hopelessness and desperation including suicidal behavior. The psychological wellness of individuals was influenced unfavorably by lifestyle changes caused by the pandemic that included isolation, limited mobility, social stigma, and ever-spreading misinformation and fake news on web-based platforms.Violence against women and girls was also exacerbated during the pandemic. Violence took place not only within the home but also in other spaces. Violence was severe among migrant workers, health workers, and sex workers. The authors underscore the urgent need for setting- up hotlines, crises centers, shelters, legal-aid, and counseling services.The pandemic might be the much-needed wake-up call to make long-term improvements in India’s healthcare system. It offers an opportunity for India to take greater cognizance of mental health problems and to integrate services to address these problems within the primary healthcare system.
4
Goforth, Harold W., and Mary Ann Cohen. "Symptoms Associated with HIV and AIDS." In Handbook of AIDS Psychiatry. Oxford University Press, 2010. http://dx.doi.org/10.1093/oso/9780195372571.003.0013.
Повний текст джерелаАнотація:
Many persons with HIV and AIDS have symptoms that are unrelated to underlying psychiatric disorders but may masquerade as such. These symptoms may include insomnia, fatigue, nausea, or other troubling symptoms, and often result in suffering for patients, their families, and loved ones. The symptoms are common throughout the course of HIV and AIDS, from onset of infection to late-stage and end-stage AIDS. They need to be addressed whenever they occur and not only as part of end-of-life care. We present protocols to ameliorate or eliminate these symptoms and alleviate suffering. Fatigue is one of the most prevalent but underreported and undertreated aspects of HIV disease. The prevalence of fatigue in an HIV population has been estimated to affect at least 50% of seropositive individuals (Breitbart et al., 1998) and may affect up to 80% of the population. Darko and colleagues (1992) found that HIV-seropositive individuals were more fatigued, required more sleep and daytime naps, and showed less alert morning functioning than did persons who are HIV-seronegative. While the symptom of fatigue may fluctuate with increasing viral loads, there is no evidence base for a consistent correlation between fatigue and viral load. Fatigue is a pseudo-specific symptom common to a variety of disabilities found in an HIV population, and it has been linked to a variety of other AIDS-related disabilities including pain, anemia, impaired physical function, psychological distress, and depression. Hormonal alterations, such as those in testosterone and thyroxin, that occur in the context of HIV infection are also common in this group. While these findings are further discussed in Chapter 10, it is worth noting here that they can contribute substantially to tiredness and fatigue in this population. Other sources of fatigue include multimorbid chronic illnesses (opportunistic infections and cancers, chronic renal insufficiency, hepatitis C and other hepatic illnesses, and chronic obstructive pulmonary disease [COPD]) and some of their treatments (notably interferon/ribavirin for hepatitis C and cancer chemotherapy). Substances such as recreational drugs, nicotine, and caffeine are also factors in HIV-related fatigue.
5
Li, Madeline, Gilla K. Shapiro, and Gary Rodin. "Anxiety and depression." In Palliative Medicine: A Case-Based Manual, 144–56. Oxford University Press, 2021. http://dx.doi.org/10.1093/oso/9780198837008.003.0013.
Повний текст джерелаАнотація:
Case studies are presented in this chapter to illustrate the attitudes, skills, and knowledge required to diagnose and manage anxiety and depression in patients who have palliative care needs. The prevalence of, and risk factors for, anxiety and depression and the clinical significance of untreated mood symptoms in this patient population are discussed. Questions that are addressed in the case examples include: What psychiatric diagnoses could be considered for the patient? Is sadness of this severity a normal part of the process of dying? How should suicidality be assessed in patients with palliative care needs? How should a wish to hasten death be explored? Psychotherapeutic and pharmacological approaches to the treatment of anxiety and depression in this patient population are also considered.
6
Maestrelli, Luiz Gustavo, Anderson Sousa Martins da Silva, and João Mauricio Castaldelli-Maia. "Depression in homeless." In Homelessness and Mental Health, edited by João Mauricio Castaldelli-Maia, Antonio Ventriglio, and Dinesh Bhugra, 215–24. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780198842668.003.0016.
Повний текст джерелаАнотація:
Homeless people form a very vulnerable group in the population and are subject to a considerable number of clinical pathologies. Similarly, they are more susceptible to psychiatric illness, including depression. According to this review, it is possible to establish that there is a high prevalence of depression in this subpopulation. This is a fact that is reflected in several cities in the world, identifying a global issue. In addition, homeless people also have high suicidal ideation, especially when having depression, further contributing to poor mental health in these individuals. Early diagnosis of depression in homeless people promotes a significant improvement in the health of these individuals. Given the great vulnerability to which the homeless are subjected, the special therapeutic attention they need is evident. The high prevalence of depression also suggests that this group does not have adequate treatment for this condition. The few intervention studies (e.g. ACCESS programme, nursing interventions, mindfulness) reported positive results in reducing depressive symptoms. Therefore, it seems possible to control depression and to increase the quality of life of homeless people affected by depression.
7
Olde Rikkert, Marcel G. M., Noemi Schuurman, and René J. F. Melis. "Phase Transitions and Resilience in Physical and Psychological Health." In Complex Systems and Population Health, 59–72. Oxford University Press, 2020. http://dx.doi.org/10.1093/oso/9780190880743.003.0005.
Повний текст джерелаАнотація:
Complexity science methods offer new opportunities for prognosis and treatment in healthcare and clinical psychology because of the increasing need for integration of the detailed knowledge of physiological and psychological subsystems and the increasing prevalence of multiple disease conditions in our aging societies. This chapter explains how the frequently occurring acute transitions and related tipping points in physical and mental processes in these populations can be monitored with time series and dynamical indicators of resilience. The authors introduce slowing down of recovery, increase in variance and autocorrelation, and increasing cross-correlation between subsystem time series as valid predictors of the proximity of tipping points in diseases such as depression, heart failure and syncope. Using wearable devices, together with these complex systems analyses, yields new methods of forecasting and may improve resilience of individual persons and their mental or physical (organ) subsystems
8
Aggarwal, Vishal R., and Joanna M. Zakrzewska. "Epidemiology of trigeminal neuralgia and its variants." In Trigeminal Neuralgia and Other Cranial Neuralgias, 27–34. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780198871606.003.0004.
Повний текст джерелаАнотація:
This chapter explores the prevalence and aetiology of trigeminal neuralgia and its variants. A summary review of prevalence studies, both population-based and hospital studies, is included. Studies showed that the prevalence of trigeminal neuralgia ranges between 0.1% and 0.7%. A lack of consistency in disease definition caused some studies to report higher prevalence which reverted to the ‘normal’ range (0.1–0.7%) when the correct disease definitions were applied. Aetiology was poorly understood although multiple sclerosis and hypertension were identified as risk factors. The burden of disease was substantial with a positive diagnosis impacting on quality of life and resulting in increased depression, anxiety, and sleep disorders. Trigeminal neuralgia and its variants are rare. The aetiology is poorly understood. Future high-quality, prospective, population-based studies are needed to identify risk factors and burden of disease. These can then be targeted to improve outcomes for patients suffering from this debilitating condition.
9
Arcelus, Jon, Fernando Fernández-Aranda, and Walter Pierre Bouman. "Eating Disorders and Disordered Eating in the LGBTQ Population." In Clinical Handbook of Complex and Atypical Eating Disorders, edited by Leslie K. Anderson, Stuart B. Murray, and Walter H. Kaye, 327–43. Oxford University Press, 2017. http://dx.doi.org/10.1093/med-psych/9780190630409.003.0019.
Повний текст джерелаАнотація:
An overall increased prevalence of eating disorders psychopathology has been reported among the LGBTQ population, particularly among gay men. For some transgender people transitioning post puberty, pressure to conform to a social gender role with the body of their assigned gender may precipitate body dissatisfaction and eating disorders as a consequence. For gay men in particular, trying to conform to specific roles, and the effect of the media, may also affect body dissatisfaction. In addition, concurrent mental health problems such as anxiety and depression may make the LGBTQ population more vulnerable to developing eating disorders. Helpful interventions for eating disorders in the LGBTQ population include addressing the maintaining factors of the eating disorder through therapy; improving interpersonal skills; and considering specific themes for this population, such as coming out, fears of rejection, and personal/societal acceptance.
10
Cullison, Jennifer. "The Deadly D’s of the Elderly." In Psychiatric Emergencies, 107–14. Oxford University Press, 2022. http://dx.doi.org/10.1093/med/9780197544464.003.0016.
Повний текст джерелаАнотація:
The deadly D’s of geriatric psychiatric emergencies—delirium, dementia, depression, and bipolar disorder—all present a challenging diagnosis for the emergency medicine physician. Delirium is often difficult to diagnose in the elderly and itself is an independent risk factor for morbidity and mortality. Dementia also affects the steadily increasing population of older adults and is associated with delirium, depression, and failure to thrive. It is well known to medicine that the prevalence of depression increases with increasing age; however, it should not be forgotten that a major depressive episode can coincide with decompensation of existing or new cases of bipolar disorder. These syndromes can exist simultaneously in the same patient and often can synergistically increase risk for each other, especially in the geriatric population. Early identification, classification, differential diagnosis, and disposition are all important in the emergency department for the timely management for these potentially life-threatening illnesses found in the complex cases of the older population.
Тези доповідей конференцій з теми "Depression prevalence in a multimorbid population"
1
Luck, T., and C. Luck-Sikorski. "Feelings of Guilt in the General Adult Population: Prevalence, Intensity and Association with Depression." In Das Soziale in Medizin und Gesellschaft – Aktuelle Megatrends fordern uns heraus 56. Jahrestagung der Deutschen Gesellschaft für Sozialmedizin und Prävention (DGSMP). Georg Thieme Verlag KG, 2021. http://dx.doi.org/10.1055/s-0041-1732733.
Повний текст джерела
2
Al-Shahwani, AlAnood, Dana Arafeh, Daniah Al-Asmar, Hiba Bawadi, Suhad Daher-Nashif, and Joyce Moawad. "Mental health problems in adults with diabetes: prevalence and potential determinants." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2021. http://dx.doi.org/10.29117/quarfe.2021.0144.
Повний текст джерелаАнотація:
Depression is associated with several chronic diseases such as diabetes. Diabetes is a long-term health disorder that have many health complications such as mental health problems, if left untreated. Our study aimed to determine the prevalence of depression among Qatari patients with diabetes, and to investigate the potential determinants of depression. Our results revealed that the prevalence of depression among the target population was 15.4%. Females, younger adults, smokers and patients with higher education had more depressive symptoms.
3
"Prevalence of Anxiety, Depression and Trauma in Baqa’a Refugee Camp." In International Conference on Public Health and Humanitarian Action. International Federation of Medical Students' Associations - Jordan, 2022. http://dx.doi.org/10.56950/gdcu6488.
Повний текст джерелаАнотація:
Aim: The general aim of this study is to screen for the prevalence of mental disorders(PTSD, anxiety and depression) amongst refugees residing in Baqaa refugee camp. Design: cross sectional quantitative study using close-ended surveys Methods: Data were collected from 124 refugees collected at baqaa refugee camp. The participants were recruited based on convenience sampling. The questionnaire included the GAD-7, PHQ-9, and part IV of the HTQ questionnaires used to screen for anxiety, depression, and symptoms of PTSD respectively. Each one of these questionnaires has its own valid and reliable scoring system that will assess how severe these mental illnesses are in the participants. For all three questionnaires, a valid Arabic translation was used, as most of the participants are fluent only in Arabic. Results: The results of this study indicated that a large portion of refugees showed signs that are indicative of suffering from mental disorders Conclusion: Our data indicate a challenging and persisting disease burden in refugees due to anxiety, depression and PTSD. Knowing this is relevant for the development of public health policies of host countries. Scalable interventions, tailored for refugees, should become more readily available. This study delved into the presence of anxiety, post-traumatic stress and depression amongst Palestinian refugees and determined that health screenings should be performed. Summary Statement What is already known about this topic? • Previous studies indicated that the quality of life in baqaa refugee camps was significantly worse than other areas in the country. • This study is one of the first one of its kind in Jordan to specifically focus on baqaa refugee camp and screen for anxiety, depression and PTSD What this paper adds? • Improving the awareness of people responsible for refugee camps about the devastating effects of mental health on the quality of life of refugees • It helps understand the population there, what kind of mental issues they are facing, which ones are most common so that governing authorities can know how to help them more efficiently. • Encourages talks about mental health and normalize seeking help especially in a group of people where mental health problems are really concentrated such as refugee camps The implications of this paper: • The researchers strongly recommend more detailed and thorough screening as well as providing refugees with options to seek therapy. Key words: Anxiety, depression, Post-traumatic stress disorder, Refugees, Mental disorders
4
Khaled, Salma Mawfek, Catalina Gabriela Petcu, Maryam Ali Al-Thani, Aisha Mohammed Al-Hamadi, and Peter Woodruff. "The association between Insomnia Disorder and Depression in the General Population of Qatar: The Role of Inflammatory Disease." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0131.
Повний текст джерелаАнотація:
Background: There is emerging evidence that supports a role for inflammatory processes and insomnia in the pathophysiology of depression. However, little is known about the role of inflammation in depression and insomnia in non-clinical populations. Aims: We aimed to estimate the association between inflammatory illness, depression and insomnia in the Qatari population. We hypothesized that inflammatory illness would be associated with sub-clinical depression and insomnia in the Qatari population. Methods: We used probability-based sampling on a representative sample (N= 1,611) of Qatar’s adult household population. Face-to-face interviews were conducted using computer-assisted technology as part of the SESRI’s annual omnibus survey in 2019. We used the Espie’s (2014) Sleep Condition Indicator, to assess insomnia symptoms, and PHQ-9 and GAD-2 for subthreshold depression (SUBD), major depressive disorder (MDD), and anxiety. Health information including personal and family history of inflammatory disease were also collected. Univariate, bivariate, and multivariate statistics were conducted. Results: Among those with no inflammatory disease, the 30-day prevalence of subthreshold and major depression in those with insomnia disorder compared to those without insomnia was (SUBD: 5.3% vs 2.9%; MDD: 7.2% vs 0.6%, P<0.001), respectively. In contrast, among respondents with inflammatory disease, the prevalence of subthreshold and major depression in those with insomnia compared to those without insomnia was (SUBD: 11.8% vs 3.6%; MDD: 17% vs 1.7%, P<0.001), respectively. In crude (adjusted for age, gender, and household type) models with depression as a dependent variable, a statistically significant association between SUBD and insomnia was found (OR=4.2, P<0.01), while much stronger association was found between major depression and insomnia (OR=20.4, P<0.001). Conclusion: These findings highlight the possible impact of inflammatory disease on mental health in the otherwise healthy population of Qatar.
5
Harrison, S., S. Ayers, MA Quigley, and F. Alderdice. "OP85 Prevalence of PTSD and comorbidity with anxiety and depression in a population-based survey of women following childbirth." In Society for Social Medicine and Population Health and International Epidemiology Association European Congress Annual Scientific Meeting 2019, Hosted by the Society for Social Medicine & Population Health and International Epidemiology Association (IEA), School of Public Health, University College Cork, Cork, Ireland, 4–6 September 2019. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/jech-2019-ssmabstracts.88.
Повний текст джерела
6
Alkhayyat, M., MA Saleh, M. Abureesh, G. Khoudari, E. Mansoor, C. Roberto Simons-Linares, T. Stevens, and P. Chahal. "INCREASING PREVALENCE OF ANXIETY AND DEPRESSION DISORDERS AFTER DIAGNOSIS OF CHRONIC PANCREATITIS: A 5 YEAR UNITED STATES POPULATION BASED STUDY." In ESGE Days. © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1704801.
Повний текст джерела
7
Schmidt, Márcia Moura, Amanda Bittencourt Lopes da Silva, Samanta Fanfa Marques, and Cynthia Seelig. "ANXIETY AND DEPRESSION IN PATIENTS SUFFERING A MYOCARDIAL INFARCTION DURING THE COVID-19 PANDEMIC." In International Psychological Applications Conference and Trends. inScience Press, 2021. http://dx.doi.org/10.36315/2021inpact026.
Повний текст джерелаАнотація:
"Introduction: Acute myocardial infarction is an experience that may cause severe emotional impact to the individual who presented it. The anxiety and depression felt is caused not only by the infarction episode itself, but also by the current uncertain state of the world during and because of the COVID-19 pandemic, something which can heighten these negative feelings throughout the entire population, especially in those considered to be in high risk groups. Objective: The objective of the present study is to estimate the prevalence of anxiety and depression among patients infarcted during the current coronavirus pandemic in the state of Rio Grande do Sul. This study will compare clinical characteristics and risk factors between groups with and without anxiety and depression. Methods: Acute myocardial infarction patients who were submitted to percutaneous coronary intervention from February to June 2020 at a reference hospital in cardiology were considered eligible. The patients were interviewed via phone calls. The clinical characteristics and intra-hospital events were obtained from the hospital’s REDCap Database. The level of anxiety and depression suffered was evaluated utilizing the HADS (Hospital Anxiety and Depression Scale). Patients considered as suffering from anxiety and depression were those who obtained scores for the possible and probable presence of those mood disorders. Patients were divided into groups with and without anxiety and depression. The categorical variables were expressed through frequency and percentage and analyzed by the Chi-square test and the continuous variables were described by average and standard deviation, and analyzed by Student's t-test. Results: A total of 55 patients were interviewed. The majority of these patients were male (74,5%) and white (80%). The average age of those participating in the study was 58 ±12 years, and the female participants were older than the males. The average number of years of education was 8 ± 4 years. The prevalence of anxiety was 38,2% and of depression 30,9%. Conclusions: The prevalence of anxiety and depression was higher than those described in the literature for this population, which supports the hypothesis that the pandemic may be aggravating the patient’s emotional state. Another group will be interviewed for the control group."
8
Nuñez Zarazu, Llerme, Nalda Nuñez Zarazu, Rosario Yslado Mendez, and Edwin Asnate Salazar. "Anxiety, Depression, Insomnia and Stress during the COVID-19 Pandemic: Prevalence and risk according to associated experiences in the general population." In ICMHI 2022: 2022 6th International Conference on Medical and Health Informatics. New York, NY, USA: ACM, 2022. http://dx.doi.org/10.1145/3545729.3545789.
Повний текст джерела
9
Melyana, Fransisca, Teguh Pribadi, and Ellya Rahma. "PREVALENCE AND PREDICTORS OF STRESS, ANXIETY, SYMPTOMS OF DEPRESSION IN HEALTH WORKERS DURING THE COVID-19 PANDEMIC." In International Conference on Public Health and Medical Sciences. Goodwood Conferences, 2022. http://dx.doi.org/10.35912/icophmeds.v1i1.32.
Повний текст джерелаАнотація:
The spread of the Coronavirus rapid 2019 and many deaths caused disruption Psychological health for health workers who work on the front lines who are in direct contact with COVID-patients19 during the pandemic. To know the relationship of demographic factors with the level of stress, anxiety, and symptoms of depression in health workers. This research is a quantitative research type with aapproach cross sectional. The population in this study were all 82 health workers at Bandar Negara Husada Hospital. Sampling with total sampling technique. Test analysis using statistical test chi square and binary logistic regression. From a total sample of 86, as many as 82 samples were willing to become respondents, with the result that the level of anxiety was 40.2% with the criteria of mild 3.7%, moderate 28% and severe 11%. Stress is 25.6% with moderate criteria 3.7% and 22% mild. Meanwhile, mild depression is 14.6%. Smoking history was a predictor of anxiety, while employment status was a predictor of depression in health workers. The prevalence of anxiety, stress, and depressive symptoms in health workers at Bandar Negara Husada Hospital, Lampung Province during the pandemic was lower than studies in other countries.
10
McGrath, N., S. McHugh, E. Toomey, and PM Kearney. "OP86 Prevalence of depression among people with diabetes; a comparative analysis of adults across three health systems using nationally representative data." In Society for Social Medicine and Population Health and International Epidemiology Association European Congress Annual Scientific Meeting 2019, Hosted by the Society for Social Medicine & Population Health and International Epidemiology Association (IEA), School of Public Health, University College Cork, Cork, Ireland, 4–6 September 2019. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/jech-2019-ssmabstracts.89.
Повний текст джерелаЗвіти організацій з теми "Depression prevalence in a multimorbid population"
1
Schnabel, Filipina, and Danielle Aldridge. Effectiveness of EHR-Depression Screening Among Adult Diabetics in an Urban Primary Care Clinic. University of Tennessee Health Science Center, April 2021. http://dx.doi.org/10.21007/con.dnp.2021.0003.
Повний текст джерелаАнотація:
Background Diabetes mellitus (DM) and depression are important comorbid conditions that can lead to more serious health outcomes. The American Diabetes Association (ADA) supports routine screening for depression as part of standard diabetes management. The PHQ2 and PHQ9 questionnaires are good diagnostic screening tools used for major depressive disorders in Type 2 diabetes mellitus (DM2). This quality improvement study aims to compare the rate of depression screening, treatment, and referral to behavioral health in adult patients with DM2 pre and post-integration of depression screening tools into the electronic health record (EHR). Methods We conducted a retrospective chart review on patients aged 18 years and above with a diagnosis of DM2 and no initial diagnosis of depression or other mental illnesses. Chart reviews included those from 2018 or prior for before integration data and 2020 to present for after integration. Sixty subjects were randomly selected from a pool of 33,695 patients in the clinic with DM2 from the year 2013-2021. Thirty of the patients were prior to the integration of depression screening tools PHQ2 and PHQ9 into the EHR, while the other half were post-integration. The study population ranged from 18-83 years old. Results All subjects (100%) were screened using PHQ2 before integration and after integration. Twenty percent of patients screened had a positive PHQ2 among subjects before integration, while 10% had a positive PHQ2 after integration. Twenty percent of patients were screened with a PHQ9 pre-integration which accounted for 100% of those subjects with a positive PHQ2. However, of the 10% of patients with a positive PHQ2 post-integration, only 6.7 % of subjects were screened, which means not all patients with a positive PHQ2 were adequately screened post-integration. Interestingly, 10% of patients were treated with antidepressants before integration, while none were treated with medications in the post-integration group. There were no referrals made to the behavior team in either group. Conclusion There is no difference between the prevalence of depression screening before or after integration of depression screening tools in the EHR. The study noted that there is a decrease in the treatment using antidepressants after integration. However, other undetermined conditions could have influenced this. Furthermore, not all patients with positive PHQ2 in the after-integration group were screened with PHQ9. The authors are unsure if the integration of the depression screens influenced this change. In both groups, there is no difference between referrals to the behavior team. Implications to Nursing Practice This quality improvement study shows that providers are good at screening their DM2 patients for depression whether the screening tools were incorporated in the EHR or not. However, future studies regarding providers, support staff, and patient convenience relating to accessibility and availability of the tool should be made. Additional issues to consider are documentation reliability, hours of work to scan documents in the chart, risk of documentation getting lost, and the use of paper that requires shredding to comply with privacy.
2
Dorman, Eleanor, Zara Markovic-Obiago, Julie Phillips, Richard Szydlo, and Darren K. Patten. Wellbeing in UK Frontline Healthcare Workers During Peaks One and Three of the COVID-19 Pandemic: A Retrospective Cross-Sectional Analysis. Science Repository, December 2022. http://dx.doi.org/10.31487/j.ejgm.2022.01.01.
Повний текст джерелаАнотація:
Background: COVID-19 had a huge impact on the wellbeing of healthcare workers (HCWs). This is well documented during the first peak of the pandemic. With cases in the UK rising for a third peak, hospitalisations and deaths surpassing the first, there is very little known about the mental health of HCWs during this time. Methods: Using a questionnaire, data was collected from patient-facing staff at Barking, Havering, and Redbridge University Trust to quantify and compare the period prevalence of symptoms of depression, anxiety, and PTSD during the first peak (P1: March-May 2020) and third peak (P3: December 2020-Feburary 2021) of the COVID-19 pandemic as well as wellbeing service use, demographics of responders and what they found most difficult during the peaks. Results: Of 158 responders, only 22·4% felt they had enough access to wellbeing services during P1 and 21·5% in P3. Of those who used wellbeing services 34·4% found them useful in P1 and 34·6% in P3. 70·3% of responders felt that not enough was done for staff wellbeing. The median anxiety score decreased from P1 (10(range 5-17)) to P3 (8(range 4-16)) p=0·031. Under 30-year-olds’ depression and PTSD scores increased from P1 to P3 (depression: P1 7(1-11), P3 8(3-14), p=0·048, PTSD: P1 4(0-7) peak 3 5(2-9), p=0·037). Several groups showed a decrease in anxiety scores from P1 to P3 including; over 30-year-olds (P1 10(5-17), P3 7(3-15) p=0·002), BME responders (P1 8(3·75-15) P3 6·5(1-12) p=0·006), AHP (P1 14(7-19), P3 11(5-19) p=0·005), ITU workers (P1 15(8-18·25) P3 12(5·75-18·25) p=0·004), and those who were redeployed (P1 8(5-18·25), P3 5(2-14·75), p=0·032). Conclusion: We have observed changes in mental health symptoms within the study population as the peaks of the pandemic continue. With the majority of responders reporting they felt not enough had been done for their wellbeing support - and of those who used the wellbeing services only around 1/3 felt they were useful - we hope that this paper can help inform wellbeing provision and identify groups at higher risk of developing mental health symptoms.